Skip to main content
SpringerLink
Log in

Dopamine induces supernumerary centrosomes and subsequent cell death through Cdk2 up-regulation in dopaminergic neuronal cells

  • Published:
Neurotoxicity Research Aims and scope Submit manuscript

Abstract

Aggregation of proteins in the centrosome is implicated in the pathophysiology of Parkinson’s disease. However, the relevance of the centrosome in neurodegeneration is still obscure. Centrosome duplication is initiated by the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex. The present study determined changes in cyclin E or Cdk2 expression and in the cen-trosomal structure in dopaminergic neuronal CATH.a cells exposed to 50, 100 and 150 μM dopamine (DA) for 24 h. DA induced significant increase in Cdk2 protein and cyclin E protein, but not cyclin e mRNA. In DA-treated cells, the intense cyclin E- and Cdk2-immunofluorescence signals were co-localized around large and supernumerary centrosomes, and these two parameters of centrosome amplification were significantly increased compared with the control. Simultaneous co-treatment with DA and a Cdk2 inhibitor blocked centrosome amplification and enhanced cell viability. Our results demonstrated that DA could lead to cyclin E accumulation and Cdk2 up-regulation triggering supernumerary centrosomes and apoptotic cell death.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alvira D, M Tajes, E Verdaguer, SG de Arriba, C Allgaier, C Matute, R Trullas, A Jimenez, M Pallas and A Camins (2007) Inhibition of cyclin-dependent kinases is neuroprotective in 1-methyl-4-phenylpyridinium-induced apoptosis in neurons.Neuroscience 146, 350–365.

    Article  CAS  PubMed  Google Scholar 

  • Andorfer C, CM Acker, Y Kress, PR Hof, K Duff and P Davies (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms.J. Neurosci. 25, 5446–5454.

    Article  CAS  PubMed  Google Scholar 

  • Asanuma M, I Miyazaki and N Ogawa (2003) Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine qui-none formation and tyrosinase in a model of Parkinson’s disease.Neurotox. Res. 5, 165–176.

    Article  Google Scholar 

  • Berman SB and TG Hastings (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson’s disease.J. Neurochem. 73, 1127–1137.

    Article  CAS  PubMed  Google Scholar 

  • Braak H, E Braak, D Yilmazer, C Schultz, RA de Vos and EN Jansen (1995) Nigral and extranigral pathology in Parkinson’s disease.J. Neural Transm. Suppl. 46, 15–31.

    CAS  PubMed  Google Scholar 

  • Ciciarello M, R Mangiacasale, M Casenghi, M Zaira Limongi, M D’Angelo, S Soddu, P Lavia and E Cundari (2001) p53 displacement from centrosomes and p53-mediated G1 arrest following transient inhibition of the mitotic spindle.J. Biol. Chem. 276, 19205–19213. Epub 12001 Feb 19228.

    Article  CAS  PubMed  Google Scholar 

  • Conway KA, JC Rochet, RM Bieganski and PT Lansbury Jr (2001) Kinetic stabilization of the a-synuclein protofibril by a dopamine-α-synuclein adduct.Science 294, 1346–1349.

    Article  CAS  PubMed  Google Scholar 

  • Cyr M, JM Beaulieu, A Laakso, TD Sotnikova, WD Yao, LM Bohn, RR Gainetdinov and MG Caron (2003) Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons.Proc. Natl. Acad. Sci. USA 100, 11035–11040.

    Article  CAS  PubMed  Google Scholar 

  • Delattre M and P Gonczy (2004) The arithmetic of centrosome biogenesis.J. Cell. Sci. 117, 1619–1630.

    Article  CAS  PubMed  Google Scholar 

  • Diaz-Corrales FJ, M Asanuma, I Miyazaki, K Miyoshi and N Ogawa (2005) Rotenone induces aggregation of γ-tubulin protein and subsequent disorganization of the centrosome: relevance to formation of inclusion bodies and neurodegen-eration.Neuroscience 133, 117–135.

    Article  CAS  PubMed  Google Scholar 

  • El-Khodor BF, TF Oo, N Kholodilov and RE Burke (2003) Ectopic expression of cell cycle markers in models of induced programmed cell death in dopamine neurons of the rat substantia nigra pars compacta.Exp. Neurol. 179, 17–27.

    Article  CAS  PubMed  Google Scholar 

  • Emdadul Haque M, M Asanuma, Y Higashi, I Miyazaki, K Tanaka and N Ogawa (2003) Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells.Biochim. Biophys. Acta 1619, 39–52.

    Google Scholar 

  • Fahn S, D Oakes, I Shoulson, K Kieburtz, A Rudolph, A Lang, CW Olanow, C Tanner and K Marek (2004) Levodopa and the progression of Parkinson’s disease.N. Engl. J. Med. 351, 2498–2508.

    Article  CAS  PubMed  Google Scholar 

  • Forno LS (1996) Neuropathology of Parkinson’s disease.J. Neuropathol. Exp. Neurol. 55, 259–272.

    Article  CAS  PubMed  Google Scholar 

  • Honda R, ED Lowe, E Dubinina, V Skamnaki, A Cook, NR Brown and LN Johnson (2005) The structure of cyclin E1/ CDK2: implications for CDK2 activation and CDK2-independent roles.EMBO J. 24, 452–463.

    Article  CAS  PubMed  Google Scholar 

  • Hoozemans JJ, MK Bruckner, AJ Rozemuller, R Veerhuis, P Eikelenboom and T Arendt (2002) Cyclin D1 and cyclin E are co-localized with cyclo-oxygenase 2 (COX-2) in pyramidal neurons in Alzheimer disease temporal cortex.J. Neuropathol. Exp. Neurol. 61, 678–688.

    CAS  PubMed  Google Scholar 

  • Husseman JW, D Nochlin and I Vincent (2000) Mitotic activation: a convergent mechanism for a cohort of neurodegen-erative diseases.Neurobiol. Aging 21, 815–828.

    Article  CAS  PubMed  Google Scholar 

  • Jellinger KA (2003) General aspects of neurodegeneration.J. Neural Transm. Suppl. 65, 101–144.

    PubMed  Google Scholar 

  • Johnson K, L Liu, N Majdzadeh, C Chavez, PC Chin, B Morrison, L Wang, J Park, P Chugh, HM Chen and SR D’Mello (2005) Inhibition of neuronal apoptosis by the cyclin-dependent kinase inhibitor GW8510: identification of 3’substituted indolones as a scaffold for the development of neuroprotective drugs.J. Neurochem. 93, 538–548.

    Article  CAS  PubMed  Google Scholar 

  • Johnston JA, CL Ward and RR Kopito (1998) Aggresomes: a cellular response to misfolded proteins.J. Cell. Biol. 143, 1883–1898.

    Article  CAS  PubMed  Google Scholar 

  • Kawamura K, H Izumi, Z Ma, R Ikeda, M Moriyama, T Tanaka, T Nojima, LS Levin, K Fujikawa-Yamamoto, K Suzuki and K Fukasawa (2004) Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E overexpression.Cancer Res. 64, 4800–4809.

    Article  CAS  PubMed  Google Scholar 

  • Klein JA and SL Ackerman (2003) Oxidative stress, cell cycle, and neurodegeneration.J. Clin. Invest. 111, 785–793.

    CAS  PubMed  Google Scholar 

  • Kopito RR (2000) Aggresomes, inclusion bodies and protein aggregation.Trends Cell. Biol. 10, 524–530.

    Article  CAS  PubMed  Google Scholar 

  • Lacey KR, PK Jackson and T Stearns (1999) Cyclin-dependent kinase control of centrosome duplication.Proc. Natl. Acad. Sci. USA 96, 2817–2822.

    Article  CAS  PubMed  Google Scholar 

  • LaVoie MJ, BL Ostaszewski, A Weihofen, MG Schlossmacher and DJ Selkoe (2005) Dopamine covalently modifies and functionally inactivates parkin.Nat. Med. 11, 1214–1221. Epub 2005 Oct 1216.

    Article  CAS  PubMed  Google Scholar 

  • Lee SS, YM Kim, E Junn, G Lee, KH Park, M Tanaka, RD Ronchetti, MM Quezado and MM Mouradian (2003) Cell cycle aberrations by α-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies.Neurobiol. Aging 24, 687–696.

    Article  CAS  PubMed  Google Scholar 

  • Lingle WL, SL Barrett, VC Negron, AB D’Assoro, K Boeneman, W Liu, CM Whitehead, C Reynolds and JL Salisbury (2002) Centrosome amplification drives chromosomal instability in breast tumor development.Proc. Natl. Acad. Sci. USA 99, 1978–1983.

    Article  CAS  PubMed  Google Scholar 

  • Marx FP, AS Soehn, D Berg, C Melle, C Schiesling, M Lang, S Kautzmann, KM Strauss, T Franck, S Engelender, J Pahnke, S Dawson, F von Eggeling, JB Schulz, O Riess and R Kruger (2007) The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein - implications for Parkinson’s disease.FASEB J. 21, 1759–1767.

    Article  CAS  PubMed  Google Scholar 

  • McNaught KS, P Shashidharan, DP Perl, P Jenner and CW Olanow (2002) Aggresome-related biogenesis of Lewy bodies.Eur. J. Neurosci. 16, 2136–2148.

    Article  PubMed  Google Scholar 

  • Moroy T and C Geisen (2004) Cyclin E.Int. J. Biochem. Cell Biol. 36, 1424–1439.

    Article  CAS  PubMed  Google Scholar 

  • Murray AW (2004) Recycling the cell cycle: cyclins revisited.Cell 116, 221–234.

    Article  CAS  PubMed  Google Scholar 

  • Nguyen MD, WE Mushynski and JP Julien (2002) Cycling at the interface between neurodevelopment and neurodegener-ation.Cell Death Differ. 9, 1294–1306.

    Article  CAS  PubMed  Google Scholar 

  • Oakley CE and BR Oakley (1989) Identification of γ-tubulin, a new member of the tubulin superfamily encoded by mipA gene of Aspergillus nidulans.Nature 338, 662–664.

    Article  CAS  PubMed  Google Scholar 

  • Ogawa N, M Asanuma, I Miyazaki, FJ Diaz-Corrales and K Miyoshi (2005) L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson’s disease.J. Neurol. 252, IV23-IV31.

    Article  PubMed  Google Scholar 

  • Olanow CW, DP Perl, GN DeMartino and KS McNaught (2004) Lewy-body formation is an aggresome-related process: a hypothesis.Lancet Neurol. 3, 496–503.

    Article  PubMed  Google Scholar 

  • Petrozzi L, C Lucetti, R Scarpato, G Gambaccini, F Trippi, S Bernardini, P Del Dotto, L Migliore and U Bonuccelli (2002) Cytogenetic alterations in lymphocytes of Alzheimer’s disease and Parkinson’s disease patients.Neurol. Sci. 23 Suppl 2, S97-S98.

    Article  PubMed  Google Scholar 

  • Sathasivam K, B Woodman, A Mahal, F Bertaux, EE Wanker, DT Shima and GP Bates (2001) Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington’s disease (HD) transgenic mice and HD patients.Hum. Mol. Genet. 10, 2425–2435.

    Article  CAS  PubMed  Google Scholar 

  • Smith MZ, Z Nagy and MM Esiri (1999) Cell cycle-related protein expression in vascular dementia and Alzheimer’s disease.Neurosci. Lett. 271, 45–48.

    Article  CAS  PubMed  Google Scholar 

  • Smith PD, SJ Crocker, V Jackson-Lewis, KL Jordan-Sciutto, S Hayley, MP Mount, MJ O’Hare, S Callaghan, RS Slack, S Przedborski, H Anisman and DS Park (2003) Cyclin- dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson’s disease.Proc. Natl. Acad. Sci. USA 100, 13650–13655.

    Article  CAS  PubMed  Google Scholar 

  • Stearns T, L Evans and M Kirschner (1991) γ-Tubulin is a highly conserved component of the centrosome.Cell 65, 825–836.

    Article  CAS  PubMed  Google Scholar 

  • Sunkel CE, R Gomes, P Sampaio, J Perdigao and C Gonzalez (1995) γ-Tubulin is required for the structure and function of the microtubule organizing centre in Drosophila neuroblasts.EMBO J. 14, 28–36.

    Google Scholar 

  • van Muiswinkel FL, RA de Vos, JG Bol, G Andringa, EN Jansen Steur, D Ross, D Siegel and B Drukarch (2004) Expression of NAD(P)H:quinone oxidoreductase in the normal and Parkinsonian substantia nigra.Neurobiol. Aging 25, 1253–1262.

    Article  PubMed  Google Scholar 

  • Whitehead RE, JV Ferrer, JA Javitch and JB Justice (2001) Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter.J. Neurochem. 76, 1242–1251.

    Article  CAS  PubMed  Google Scholar 

  • Wigley WC, RP Fabunmi, MG Lee, CR Marino, S Muallem, GN DeMartino and PJ Thomas (1999) Dynamic association of proteasomal machinery with the centrosome.J. Cell. Biol. 145, 481–490.

    Article  Google Scholar 

  • Xu J, SY Kao, FJ Lee, W Song, LW Jin and BA Yankner (2002) Dopamine-dependent neurotoxicity of a-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.Nat. Med. 8, 600–606.

    Article  CAS  PubMed  Google Scholar 

  • Xu Y, AH Stokes, RJ Roskoski and KE Vrana (1998) Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase.J. Neurosci. Res. 54, 691–697.

    Article  CAS  PubMed  Google Scholar 

  • Yoshimoto Y, K Nakaso and K Nakashima (2005) L-dopa and dopamine enhance the formation of aggregates under protea- some inhibition in PC12 cells.FEBS Lett. 579, 1197–1202.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Brain Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikatacho, 700-8558, Okayama, Japan

    Francisco J. Diaz-Corrales, Masato Asanuma, Ikuko Miyazaki, Ko Miyoshi & Norio Ogawa

  2. Department of Neurology, Juntendo University School of Medicine, 113-8421, Tokyo, Japan

    Nobutaka Hattori

Authors
  1. Francisco J. Diaz-Corrales
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masato Asanuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ikuko Miyazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ko Miyoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nobutaka Hattori
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Norio Ogawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masato Asanuma.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diaz-Corrales, F.J., Asanuma, M., Miyazaki, I. et al. Dopamine induces supernumerary centrosomes and subsequent cell death through Cdk2 up-regulation in dopaminergic neuronal cells. neurotox res 14, 295–305 (2008). https://doi.org/10.1007/BF03033854

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03033854

Keywords

Search

Navigation